Company Information for CELEX ONCOLOGY INNOVATIONS LIMITED
101 NEW CAVENDISH STREET, 1ST FLOOR SOUTH, LONDON, W1W 6XH,
|
Company Registration Number
![]() Private Limited Company
Active |
Company Name | |
---|---|
CELEX ONCOLOGY INNOVATIONS LIMITED | |
Legal Registered Office | |
101 NEW CAVENDISH STREET 1ST FLOOR SOUTH LONDON W1W 6XH | |
Company Number | 11085607 | |
---|---|---|
Company ID Number | 11085607 | |
Date formed | 2017-11-28 | |
Country | UNITED KINGDOM | |
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active | |
Lastest accounts | 31/12/2022 | |
Account next due | 30/09/2024 | |
Latest return | ||
Return next due | 26/12/2018 | |
Type of accounts | TOTAL EXEMPTION FULL | |
VAT Number /Sales tax ID | GB333152241 |
Last Datalog update: | 2024-04-06 19:41:40 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
LAURENCE JOHN COHEN |
||
MUSTAFA BILGIN ALI DJAMGOZ |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
EDGE PETROL LIMITED | Director | 2016-12-15 | CURRENT | 2015-06-11 | Active | |
INAP ONCOLOGY LIMITED | Director | 2013-10-28 | CURRENT | 2013-10-28 | Dissolved 2017-03-28 | |
TURKUAS-UK | Director | 2013-05-10 | CURRENT | 2013-05-10 | Dissolved 2014-12-23 | |
NAVION LIMITED | Director | 2008-11-28 | CURRENT | 2008-07-11 | Dissolved 2014-03-18 | |
PRO CANCER RESEARCH FUND | Director | 2001-10-29 | CURRENT | 2001-10-29 | Active |
Date | Document Type | Document Description |
---|---|---|
DIRECTOR APPOINTED DR RACHED SAMI BAKRI | ||
24/03/24 STATEMENT OF CAPITAL GBP 683.489338 | ||
24/03/24 STATEMENT OF CAPITAL GBP 722.921402 | ||
24/03/24 STATEMENT OF CAPITAL GBP 755.781488 | ||
24/03/24 STATEMENT OF CAPITAL GBP 762.353466 | ||
24/03/24 STATEMENT OF CAPITAL GBP 765.639504 | ||
24/03/24 STATEMENT OF CAPITAL GBP 768.268354 | ||
24/03/24 STATEMENT OF CAPITAL GBP 774.840332 | ||
24/03/24 STATEMENT OF CAPITAL GBP 778.12637 | ||
24/03/24 STATEMENT OF CAPITAL GBP 780.75522 | ||
24/03/24 STATEMENT OF CAPITAL GBP 783.38407 | ||
24/03/24 STATEMENT OF CAPITAL GBP 786.01292 | ||
24/03/24 STATEMENT OF CAPITAL GBP 788.64177 | ||
24/03/24 STATEMENT OF CAPITAL GBP 791.27062 | ||
24/03/24 STATEMENT OF CAPITAL GBP 793.89947 | ||
25/03/24 STATEMENT OF CAPITAL GBP 811.04947 | ||
25/03/24 STATEMENT OF CAPITAL GBP 825.74947 | ||
25/03/24 STATEMENT OF CAPITAL GBP 840.44947 | ||
CONFIRMATION STATEMENT MADE ON 05/04/24, WITH UPDATES | ||
09/02/24 STATEMENT OF CAPITAL GBP 440.162786 | ||
09/02/24 STATEMENT OF CAPITAL GBP 459.762786 | ||
14/02/24 STATEMENT OF CAPITAL GBP 477.84604 | ||
14/02/24 STATEMENT OF CAPITAL GBP 598.401328 | ||
09/02/24 STATEMENT OF CAPITAL GBP 608.201328 | ||
19/03/24 STATEMENT OF CAPITAL GBP 637.601328 | ||
19/03/24 STATEMENT OF CAPITAL GBP 657.201328 | ||
APPOINTMENT TERMINATED, DIRECTOR MUSTAFA BILGIN ALI DJAMGOZ | ||
CONFIRMATION STATEMENT MADE ON 04/12/23, WITH UPDATES | ||
REGISTERED OFFICE CHANGED ON 03/04/23 FROM 64 New Cavendish Street London W1G 8TB England | ||
CONFIRMATION STATEMENT MADE ON 04/12/22, WITH UPDATES | ||
Sub-division of shares on 2022-08-15 | ||
Resolutions passed:<ul><li>Resolution Nominal value of each share be sub dividend 15/08/2022</ul> | ||
15/08/22 STATEMENT OF CAPITAL GBP 0.0001 | ||
SH01 | 15/08/22 STATEMENT OF CAPITAL GBP 0.0001 | |
RES13 | Resolutions passed:
| |
AA | 31/12/21 ACCOUNTS TOTAL EXEMPTION FULL | |
CS01 | CONFIRMATION STATEMENT MADE ON 04/12/21, WITH NO UPDATES | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR AJMAL RAHMAN | |
AA | 31/12/20 ACCOUNTS TOTAL EXEMPTION FULL | |
CS01 | CONFIRMATION STATEMENT MADE ON 04/12/20, WITH UPDATES | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
RES01 | ADOPT ARTICLES 04/11/20 | |
AD01 | REGISTERED OFFICE CHANGED ON 26/10/20 FROM 9th Floor, the Royal Liver Building Pier Head Liverpool L3 1JH United Kingdom | |
RP04SH01 | Second filing of capital allotment of shares GBP400 | |
AA | 31/12/19 ACCOUNTS TOTAL EXEMPTION FULL | |
AP01 | DIRECTOR APPOINTED MR AJMAL RAHMAN | |
RES12 | Resolution of varying share rights or name | |
PSC04 | Change of details for Professor Mustafa Bilgin Ali Djamgoz as a person with significant control on 2020-06-08 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR BRIAN PERCIVAL DE THORPE MILLARD | |
PSC07 | CESSATION OF VASILEIOS XENIADES AS A PERSON OF SIGNIFICANT CONTROL | |
CS01 | CONFIRMATION STATEMENT MADE ON 04/12/19, WITH UPDATES | |
AP01 | DIRECTOR APPOINTED MR BRIAN PERCIVAL DE THORPE MILLARD | |
SH01 | 25/09/19 STATEMENT OF CAPITAL GBP 571.43 | |
PSC01 | NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL VASILEIOS XENIADES | |
PSC07 | CESSATION OF LAURENCE JOHN COHEN AS A PERSON OF SIGNIFICANT CONTROL | |
SH02 | Sub-division of shares on 2019-07-28 | |
RES13 | Resolutions passed:
| |
SH01 | 05/08/19 STATEMENT OF CAPITAL GBP 100 | |
AP01 | DIRECTOR APPOINTED MR CARSTEN KRONSBJERG FALTUM | |
AA | ACCOUNTS FOR DORMANT COMPANY MADE UP TO 31/12/18 | |
CS01 | CONFIRMATION STATEMENT MADE ON 04/12/18, WITH NO UPDATES | |
CS01 | CONFIRMATION STATEMENT MADE ON 27/11/18, WITH NO UPDATES | |
AA01 | Current accounting period extended from 30/11/18 TO 31/12/18 | |
CH01 | Director's details changed for Professor Musfafa Bilgin Ali Djamgoz on 2017-11-28 | |
PSC04 | Change of details for Professor Musfafa Bilgin Ali Djamgoz as a person with significant control on 2017-11-28 | |
LATEST SOC | 28/11/17 STATEMENT OF CAPITAL;GBP 2 | |
NEWINC | New incorporation |
Total # Mortgages/Charges | 0 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 0 |
Average | Max |
This shows the max and average number of mortgages for companies with the same SIC code of 21100 - Manufacture of basic pharmaceutical products
|
|
|
|
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on CELEX ONCOLOGY INNOVATIONS LIMITED
The top companies supplying to UK government with the same SIC code (21100 - Manufacture of basic pharmaceutical products) as CELEX ONCOLOGY INNOVATIONS LIMITED are:
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |